跳至主要内容
临床试验/CTRI/2022/06/043302
CTRI/2022/06/043302已完成2 期

An open labelled double arm non randomized Phase-II clinical trial to evaluate the efficacy of Siddhar yoga maruthuva muraigal and siddha medicine CHITARATHAI PODI(internal medicine)in the management of MANTHARA KAASAM

Dr A VIGNESHWARI1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年6月27日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Reduce the symptoms of Allergic Ashthma

研究概览

简要总结

It is an open labelled double arm non randomized Phase -II clinical trial to evaluate the efficacy of siddhar yoga maruthuva muraigal and Siddha medicine CHITARATHAI PODI(internal medicine )in the management of MANTHARA KAASAM

CHITARATHAI PODI

DOSAGE: 2 to 4 gm twice a day

Along with Siddhar Yoga maruthuva muraiga

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)

入选标准

  • Age between 20years to 70years Gender Both Male & Female Patient have symptoms of Allergic Rhinitis Fever cough with or without expectoration wheezing History of Bronchial Asthma continous sneezing excessive sweating Patient who are willing to give radilogical investigation and provide blood for lab investigation Patient who are willing to participate in this studywith the knowledge of potential risk and who are willing to sign the informed consent form.

排除标准

  • Age below 20yrs and above 70years Patients who face difficulties or hesitate to participate yoga are excluded History of Fracture within one year Tumour Patient who have cardiac illness Diabetes Patient have any surgical history within 3 months.

结局指标

主要结局

Reduce the symptoms of Allergic Ashthma

时间窗: Reduce the symptoms of Allergic Ashthma

次要结局

未报告次要终点

研究者

发起方
Dr A VIGNESHWARI
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验